| Financial Year |
September 30 2020 |
| Monetary Funds |
5,004,931,888.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,254,755.26 |
| Accounts Receivable |
1,842,669,024.68 |
| Advances to Suppliers |
900,720,140.57 |
| Other Receivables |
32,951,919.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,888,680,186.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
507,300,295.29 |
| Total Current Assets |
11,727,846,011.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
176,393,802.96 |
| Long-term Equity Investment |
934,096,354.76 |
| Investment Properties |
55,940,913.15 |
| Fixed Assetes |
7,478,338,759.01 |
| Under-construction Projects |
2,204,136,616.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,502,413,324.94 |
| R&D expenses |
-- |
| Goodwill |
5,636,985,265.15 |
| Long-Term Deferred and Prepaid Expenses |
114,848,516.09 |
| Deferred Income Tax Assets |
244,815,648.31 |
| Other Non-Current Assets |
431,627,962.47 |
| Sub-Total of Non-Current Assets |
19,119,088,338.68 |
| Total Assets |
30,846,934,350.47 |
| Short-Term Loans |
3,646,311,535.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,686,456,557.24 |
| Accounts Payable |
1,946,985,260.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
141,081,357.05 |
| Taxes Payable |
177,476,985.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
444,919,536.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
333,778,338.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
11,646,708,547.01 |
| Long-term Loans |
4,148,162,220.76 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
121,787,022.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
50,911,499.19 |
| Deferred Income Tax Liabilities |
219,285,313.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,809,172,268.23 |
| Total Liabilities |
16,455,880,815.24 |
| Paid-In Capital(Or Share Stock) |
2,032,020,889.00 |
| Capital Surplus |
9,559,861,741.88 |
| Surplus Reserve |
650,571,671.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,778,932,013.08 |
| Minority Stockholder's Interest |
317,976,039.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,073,077,496.07 |
| Owner's Equity（Stockholder's Equity） |
14,391,053,535.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,846,934,350.47 |
